Paper39669195
Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.
Huang K and 5 others. Front Pharmacol, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis. Papers, record 39669195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39669195
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24559811 | Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial. | Complement Ther Med | 2014 | https://conductscience.org/library/papers/24559811 | PubMed |
| 2 | 21437019 | Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths? | Gastroenterol Hepatol (N Y) | 2010 | https://conductscience.org/library/papers/21437019 | PubMed |
| 3 | 25161692 | Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. | Evid Based Complement Alternat Med | 2014 | https://conductscience.org/library/papers/25161692 | PubMed |
| 4 | 26558923 | Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. | Expert Opin Pharmacother | 2015 | https://conductscience.org/library/papers/26558923 | PubMed |
| 5 | 32623701 | Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial. | Chin J Integr Med | 2020 | https://conductscience.org/library/papers/32623701 | PubMed |
| 6 | 32961342 | Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/32961342 | PubMed |
| 7 | 27487786 | Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial. | Chin J Integr Med | 2018 | https://conductscience.org/library/papers/27487786 | PubMed |
| 8 | 27308645 | Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. | J Gastrointestin Liver Dis | 2016 | https://conductscience.org/library/papers/27308645 | PubMed |
| 9 | 31463606 | Placebos and the Placebo Effect in Drug Trials. | Handb Exp Pharmacol | 2019 | https://conductscience.org/library/papers/31463606 | PubMed |
| 10 | 14984373 | Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. | Aliment Pharmacol Ther | 2004 | https://conductscience.org/library/papers/14984373 | PubMed |
| 11 | 35943515 | Placebo: a brief updated review. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | https://conductscience.org/library/papers/35943515 | PubMed |
| 12 | 22008217 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. | BMJ | 2011 | https://conductscience.org/library/papers/22008217 | PubMed |
| 13 | 29856472 | Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome. | Aliment Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29856472 | PubMed |
| 14 | 34304784 | Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective. | Gastroenterol Clin North Am | 2021 | https://conductscience.org/library/papers/34304784 | PubMed |
| 15 | 12138321 | A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula. | Digestion | 2002 | https://conductscience.org/library/papers/12138321 | PubMed |
| 16 | 33192627 | Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/33192627 | PubMed |
| 17 | 7119132 | An investigation of drug expectancy as a function of capsule color and size and preparation form. | J Clin Psychopharmacol | 1982 | https://conductscience.org/library/papers/7119132 | PubMed |
| 18 | 24660584 | Curative effect of warming kidney and fortifying spleen recipe on diarrhea-predominant irritable bowel syndrome. | J Tradit Chin Med | 2013 | https://conductscience.org/library/papers/24660584 | PubMed |
| 19 | 35483627 | Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial. | Complement Ther Med | 2022 | https://conductscience.org/library/papers/35483627 | PubMed |
| 20 | 26133902 | Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial. | Clin Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/26133902 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42688762 | Pathogenesis and therapeutic strategies for irritable bowel syndrome: an integrated perspective from dynamic balance theory of Chinese medicine. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42688762 | PubMed |
| 42614517 | Multidimensional evaluation of four chaihu-shugan-san simulated decoction for use as placebo controls: a comparative study. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42614517 | PubMed |
| 42065756 | Pathophysiology-driven use of natural products in irritable bowel syndrome: a review. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42065756 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39669195
GET https://conductscience.org/api/papers/v1/39669195/references?page=2